Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern

PLoS Pathogens(2022)10.1371/journal.ppat.1010686Source: DataRank Database

Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern is a research paper published in PLoS Pathogens (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

gen gisaid pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.58)OA: goldTopics (66)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Alex E. Clark ORCID,Valentina L. Kouznetsova ORCID,Eduardo Olmedillas ORCID,Andrea Castro ORCID,Igor F. Tsigelny ORCID

Live enrichment

PubMed:35862442 PMC:PMC9302722 OpenAlex:https://openalex.org/W4286491896

National Institute of Allergy and Infectious Diseases

Grant: K08AI130381

National Institute of Allergy and Infectious Diseases

Grant: U19 142790-S1

Bill and Melinda Gates Foundation

Grant: INV-006133

National Institutes of Health

Grant: 5K08AI130381-05

Deconvolution of pro- and anti-viral responses to Dengue virus and Zika Virus infections

National Institutes of Health

Grant: 5U19AI142790-04

Consortium for Immunotherapeutics against Emerging Viral Threats

FWCI

0.58

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010686&type=printable

publisherhttps://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010686&type=printable

publisherhttps://dx.plos.org/10.1371/journal.ppat.1010686

journalhttps://doi.org/10.1371/journal.ppat.1010686

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35862442

Fields of Study

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesViral Infections and Immunology Research0301 basic medicine03 medical and health sciencesAnimalsAntibodies, NeutralizingAntibodies, ViralCOVID-19MiceMice, Inbred C57BLPandemicsSARS-CoV-2Spike Glycoprotein, CoronavirusSARS-CoV-2 variants

MeSH Terms

COVID-19SARS-CoV-2AnimalsAntibodies, ViralMice, Inbred C57BLMiceAntibodies, NeutralizingPandemicsSpike Glycoprotein, Coronavirus

Keywords

Polyclonal antibodiesAntibodyVirologyBiologyHypervariable regionPriming (agriculture)Neutralizing antibodyVirusRecombinant DNAFragment crystallizable regionGeneticsGeneQH301-705.5ImmunologyInbred C57BLAntibodies, ViralMicrobiologyAntibodiesVaccine RelatedMiceAnimalsViralBiology (General)NeutralizingPandemicsBiomedical and Clinical SciencesSARS-CoV-2PreventionCOVID-19Medical microbiologyRC581-607Antibodies, NeutralizingSpike GlycoproteinCoronavirusMice, Inbred C57BLEmerging Infectious DiseasesGood Health and Well BeingSpike Glycoprotein, CoronavirusImmunizationImmunologic diseases. AllergyInfectionResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being